Posted by Clinical Lab Products | Feb 6, 2005 | Cancer, Miscellaneous |
By Nicholas Borgert Widespread use of the fibrous silicate material asbestos may be on its way out, but concern about the diseases it causes has caught the eye of at least one test developer: Fujirebio Diagnostics Inc (FDI). Asbestos has been u
Read MorePosted by Clinical Lab Products | Jul 12, 2004 | Cancer, Miscellaneous, Osteoporosis |
Roche and Premier Continue Partnership Roche Diagnostics Corp and Premier Purchasing Partners LLP have signed a 3-year agreement in which Roche will continue to provide instruments, reagents, and consumables to Premier members. The contract includ
Read MorePosted by Clinical Lab Products | Jun 2, 2004 | Cancer, Miscellaneous |
By Gary Tufel Obesity has been previously acknowledged as a causative factor for a range of diseases, including cardiac problems and diabetes. Now research has clearly demonstrated obesity’s link to cancer. According to Colleen Doyle, MS, R
Read MorePosted by Clinical Lab Products | May 9, 2004 | Cancer, Miscellaneous |
Study Finds Improved Detection of Cervical Cancer A group of physicians recently found that detection of precancerous changes in the cervix improved by more than 26% when a new optical detection system (ODS) was used in conjunction with colposcopy
Read MorePosted by Clinical Lab Products | May 1, 2004 | Cancer, Miscellaneous |
By Marleen and Gary Wolfe The past year was a busy one worldwide for clinical microbiologists as they responded to one medical crisis after another. Outbreaks of new diseases, such as SARS (severe acute respiratory syndrome), and virulent new str
Read More